Agenus Inc.Agenus Inc.Agenus Inc.

Agenus Inc.

No trades
See on Supercharts
Market capitalization
‪170.71 M‬USD
−13.88USD
‪−245.76 M‬USD
‪156.31 M‬USD
‪19.91 M‬
Beta (1Y)
1.58

About Agenus Inc.

CEO
Garo H. Armen
Headquarters
Lexington
Employees (FY)
389
Founded
1994
ISIN
US00847G8042
FIGI
BBG000C8SWQ9
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AGEN is 8.15 USD — it has decreased by 8.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Agenus Inc. stocks are traded under the ticker AGEN.
Agenus Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Agenus Inc. has a max estimate of 160.00 USD and a min estimate of 60.00 USD.
AGEN earnings for the last quarter are −3.20 USD whereas the estimation was −3.90 USD which accounts for 17.98% surprise. Estimated earnings for the next quarter are −1.07 USD. See more details about Agenus Inc. earnings.
Agenus Inc. revenue for the last quarter amounts to ‪24.31 M‬ USD despite the estimated figure of ‪24.33 M‬ USD. In the next quarter revenue is expected to reach ‪47.05 M‬ USD.
Yes, you can track Agenus Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, AGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Agenus Inc. stock right from TradingView charts — choose your broker and connect to your account.
AGEN reached its all-time high on Feb 7, 2000 with the price of 8580.00 USD, and its all-time low was 7.02 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 389.00 employees. See our rating of the largest employees — is Agenus Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Agenus Inc. EBITDA is ‪−146.52 M‬ USD, and current EBITDA margin is −93.73%. See more stats in Agenus Inc. financial statements.